Asset Management Awards Day 4: Marquee winners

Fund Managers Awards

The Editors

Apr 10, 2018

For our final set of Asset Management Awards for 2018, AsianInvestor we reveal the marquee award winners for asset management and asset servicing.

Today AsianInvestor is very excited to conclude our annual Asset Management awards by revealing the marquee award winners of 2018. We have already revealed the winning...

0 0 0 0 0

Just Published

Asset Owners

11 hours ago

Jolie Ho

The group CIO of the third-largest insurer in China discusses how the lifer is going to lengthen asset duration and possibly increase overseas exposure.

Asset Owners

11 hours ago

Jaycee Man

China Pacific Insurance's CIO and other market specialists share their views on how US monetary policy could play out in coming months, and what that could mean for investments.

Asset Owners

12 hours ago

Richard Newell

With public markets set to face a challenging 2019, institutional investors will need to stay diversified to protect portfolios. A dynamic approach that blends different styles of investing can help.

Asset Management Awards Day 4: Marquee winners

Follow Us

Most Read

Eastspring’s C-suite shakeup fuels sell-off talk

BNP Paribas AM hires from Conning for quant buildout

Weekly roundup of people news, Feb 15

Zurich’s HK, Singapore units to enter private debt

Alternatives giant Ares raids UBS for Asia push

EPF plans to raise property and infra exposure

Singapore Life set to add managers, expand regionally

MPF urged to allow A-share, HK fund, Reit investments

CPIC Life to raise its exposure to private equity

Zurich strives to cut HK portfolio duration gap

Related Articles

Asset Management Awards 2019 – request for pitches

Photos: Asset Management Awards 2018

Asset Management Awards 2018: The final winners

Asset Management Awards 2018 day 1: Asset Class awards

Just Published

How CPIC Life seeks to close duration gap

Market Views: Where next for US interest rates?

Asset owners need ‘multi-faceted’ approach to risk

Next-gen sequencing: Why gene research delivers returns to investors